|
 |
Metoprolol SuccinateThis page contains recent news articles, when available, and an overview of Metoprolol Succinate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.The company said that the recent quarter revenue increase was principally driven by the lack of competition in metoprolol succinate and meclizine, RTT News Watson's Metoprolol Could Hurt Par Pharmaceutical - Aug 26, 2009 Par Pharmaceuticals has generated substantial revenues from its Metoprolol succinate ER (Toprol-XL®) product over the past year. In fact, the generic drug Sumfolio.com Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009 - Aug 4, 2009 Metoprolol: For the quarter ended June 27, 2009, net sales of metoprolol succinate reached $306 million, an increase of 173% from the first quarter 2009. PR Newswire (press release) Watson Says FDA May Approve Generic Toprol-Xl Soon - Aug 7, 2009 Approval of generic Toprol-XL (metoprolol succinate) in 25- and 50-mg strengths may come first, and the company expects FDA approval for the 100- and 200-mg FDA news (subscription) Orbus Announces Regulatory Approvability for Metoprolol Succinate ... - Aug 11, 2009 The Orbus Metoprolol Succinate XR formulation is a generic version of AstraZeneca's Beloc-Zok(r) in Europe. "Notification of approvability from the BfArM is FOXBusiness Pharmacist House Calls Cut HF Hospitalizations - Aug 20, 2009 ...or metoprolol succinate, for heart failure. These patients were compared to 5444 control patients who didn't have their medications reviewed. MedPage Today Pharmacist-doctor teams help keep heart-failure patients out of ... - Aug 18, 2009 ...or metoprolol succinate for heart failure and compared 273 patients who received general practitioner-pharmacist collaborative home medication review TheHeart.Org HMRs stave off hospital visits - Aug 23, 2009 ...carvedilol or metoprolol succinate and analysed the impact of home medicine reviews (HMRs) performed collaboratively between pharmacists and doctors. Pharmacy News Charles Bonnet syndrome: visual loss and hallucinations - Aug 3, 2009 ...acetylsalicylic acid, clopidogrel bisulfate, glimepiride, hydrochlorothiazide, furosemide, lisinopril, metoprolol succinate, simvastatin and tramadol. CMAJ Orbus Pharma Inc. Second Quarter 2009 Results and Corporate Update ... - Aug 6, 2009 Metoprolol Succinate XR has confirmatory small scale pilot bioequivalent studies for both the USA and European products underway that are scheduled for FOXBusiness Par Pharmaceutical 盈馀超越预期 - Aug 4, 2009 ...è?¥æ”¶æˆ?长，主è¦?æ˜¯å› metoprolol succinate与meCLizine没有竞争压力，以å?Š2008年下å?Šå¹´æ–°æŽ¨å‡ºsumatriptan注射剂与dronabinol。 å…?责声明：本文仅代表作者个人观点，与 凤凰网 Problem Drugs Force FDA To Sieze Manufacturers - Jul 8, 2009 Metoprolol Succinate was the twenty-four hour version of the drug. A lot of people were taking Metoprolol S. When KV Pharm issued their recall, Lez Get Real WORDS TO LIVE BY FOR YOUR - Jun 18, 2009 For people whose doctors have prescribed a beta-blocker called TOPROL-XL or its generic formulation, metoprolol succinate extended-release tablets, North American Press Syndicate BUYINS.NET: HNR, PRX, MENT, NLS, RTI, PQ Are Seasonally Biased To ... - Jul 2, 2009 Its principal generic products include Metoprolol succinate ER, Fluticasone, Meclizine Hydrochloride, Cabergoline, Sumatriptan succinate injection, Trading Markets (press release) Anestezjologia i intensywna terapia - postÄ™py 2008 - Jun 26, 2009 POISE Study Group: Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomized controlled trial. Medycyna Praktyczna Effects of β-Blocker Titration on Glucose Homeostasis in Heart Failure - 20 Apr 2009 OBJECTIVE: To evaluate the effects of metoprolol succinate or carvedilol up-titration on fasting glucose, insulin resistance, and β 2 -mediated glucose The Journal of Pharmacy Technology Orbus Announces Signing Of Anda Development, Manufacturing and ... - Mar 30, 2009 The Metoprolol Succinate extended release tablet is a once a day beta blocker that can be used alone or in combination with other medications to treat high FOXBusiness FDA Safety Changes: Toprol XL, Revlimid, Fludara - Apr 15, 2009 On February 12, the FDA approved safety labeling revisions for metoprolol succinate (Toprol-XL extended-release tablets; AstraZeneca LP) to provide Medscape Par Pharmaceutical Reports Fourth Quarter and Full Year 2008 Results - Mar 2, 2009 ...the launch of dronabinol in July, and the launch of sumatriptan succinate in November, and increased sales of metoprolol succinate to new customers. PR Newswire (press release) People's Pharmacy: Can the FDA be fixed? - Mar 15, 2009 Among them were metoprolol succinate and nitroglycerin sublingual tablets. As a result, shortages of these important heart medicines have developed. Houston Chronicle Growth in Health Care Spending Slows, But Still Outpaces Rate of ... - Feb 24, 2009 In 2007, amlodipine besylate, amlodipine and benazepril, carvedilol, metoprolol succinate, and zolpidem lost patent exclusivity. The 7.3% hospital spending Journal of American Medical Association (subscription) 10-K: WATSON PHARMACEUTICALS INC - Feb 23, 2009 ...on sales by Sandoz of metoprolol succinate 50 mg extended-release tablets which were all negatively impacted by the introduction of competing products. MarketWatch (press release) Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 ... - Feb 20, 2009 Generic other revenue decreased $28.0 million to $2.1 million, due primarily to a decline in royalties related to Sandoz's sales of metoprolol succinate Lifescience-online Metoprololo nell'ipertensione pediatrica - Feb 22, 2009 Efficacy and Safety of Extended Release Metoprolol Succinate in Hypertensive Children 6 to 16 Years of Age: A Clinical Trial Experience. Pillole.org Dozens of generic drugs recalled - 04 Feb 2009 ...more than 60 generic drugs distributed to wholesalers, and two generic drugs, hydromorphone HCl and metoprolol succinate, distributed to retailers. MiamiHerald.com, Metoprolol Succinate Recalled: Brand Name Drug Scarce But Still ... - Jan 30, 2009 Due to recent recalls, many US pharmacies are now out-of-stock of the popular beta-blocker metoprolol succinate. The original, brand name version, PR Web (press release), Toprol-XL Competitors Hampered by Production Issues - Feb 2, 2009 KV Pharmaceutical and Novartis’ Sandoz unit are the only companies that have FDA approval to manufacture generic Toprol-XL (metoprolol succinate). FDA news (subscription), Generic Toprol XL Scarce, After Problems at Novartis and KV - Jan 28, 2009 Novartis tells the Health Blog that it hasn’t yet been able to resume shipping supplies of the generic beta blocker, metoprolol succinate ER. Wall Street Journal Blogs, Ethex Corp. expands generic drug recall - Jan 30, 2009 ...pharmaceuticals (Hydromorphone HCI tablets - 2mg, 4 mg and 8mg - and Metoprolol Succinate ER tablets - 25mg, 50mg, 100mg and 200mg) included as well. AAP News (subscription) Another Ethex and KV Pharma Drug Recall - Feb 2, 2009 ETHEX Corporation has initiated recall notifications to wholesalers (and to retailers for Hydromorphone HCl and Metoprolol Succinate only) nationwide who InjuryBoard.com, US shortage of blood pressure drug affects Tulsans - Jan 31, 2009 ...shipping of all its products, including prescription metoprolol succinate tablets, amid concerns they may contain excess doses of the active ingredient. Tulsa World, Labaton Sucharow LLP Filed a Class Action Lawsuit Against KV ... - Jan 21, 2009 ...the expiration of the Company's exclusive sales period for the drug metoprolol succinate; (7) that KV's financial statements failed to comply with GAAP; MSNBC Milberg LLP Announces Its Investigation on Behalf of Certain ... - Jan 14, 2009 ...sales period for the drug metoprolol succinate; (vii) that KV's financial statements failed to comply with Generally Accepted Accounting Principles; CNNMoney.com Cohen Milstein Announces That It Has Filed A Securities Class ... - Jan 9, 2009 ...sales period for the drug metoprolol succinate; and (vii) that KV’s financial statements failed to comply with Generally Accepted Accounting Principles. Earthtimes (press release), December 2008 Mayo Clinic Health Letter Highlights: Colorectal ... - Dec 9, 2008 ...legs syndrome -- Toprol-XL (metoprolol succinate) for blood pressure, heart failure and angina -- Zyrtec-D (cetirizine/pseudoephedrine) for allergies. MarketWatch Izard Nobel LLP Announces Class Action Lawsuit Against KV ... - Dec 5, 2008 ...(vi) that KV's post-January 2008 sales of generics declined following the expiration of KV's exclusive sales period for the drug metoprolol succinate. CNNMoney.com Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit ... - Dec 2, 2008 ...sales period for the drug metoprolol succinate; (vii) that KV’s financial statements failed to comply with Generally Accepted Accounting Principles; WELT ONLINE, Comparative Effectiveness of β-Blockers in Elderly Patients With ... - Dec 8, 2008 ...metoprolol succinate, and bisoprolol fumarate (evidence-based β-blockers [EBBBs]) improve survival in patients with heart failure (HF) is unknown. Archives of Internal Medicine Company and People Notes: BMS and AstraZeneca Expand Collaboration ... - Dec 11, 2008 3)—The US Food and Drug Administration announced a recall of 6.37 million bottles of Sandoz’s (Princeton, NJ) generic metoprolol succinate extended-release Pharmaceutical Technology Magazine, KV Pharmaceutical Company Provides Additional Financial, Business ... - Nov 17, 2008 Contribution of $72.6 million in net sales for the first six months of fiscal 2009 from all four strengths of metoprolol succinate extended-release tablets, MarketWatch Sandoz lays off 30, but may soon boost employment - Nov 22, 2008 Good Manufacturing Practice regulations in the manufacturing of drug products, which include Metoprolol Succinate ER tablets, according to the Aug. Trading Markets (press release), AstraZeneca reports strong third quarter - Oct 31, 2008 A $141 million loss of Toprol XL (metoprolol succinate) sales to generic competition counteracted the 5% increase in the rest of the US business Scrip World Pharmaceutical News (subscription), Orbus Pharma Inc. Reports Third Quarter 2008 Results - Nov 13, 2008 Metoprolol Succinate XR: "Push" for market authorization in both Europe and the United States as soon as possible. We have validated our marketing FOXBusiness Meta-Analysis Questions Safety of Perioperative Beta Blocker Use - Nov 13, 2008 They did point out that it cannot be excluded that the high (starting) dose of metoprolol succinate that was used in POISE might have caused an unfavorable MedPage Today, Beta Blockers Up Risk of MI, Death After Noncardiac Operations - Oct 29, 2008 Specific beta-blockers used included metoprolol succinate or metoprolol tartrate, atenolol, and propranolol hydrochloride. The preoperative heart rate, Medscape (registration) Watson Pharmaceuticals Reports Third Quarter 2008 Results - Oct 29, 2008 Generic other revenue decreased $19.9 million to $11.6 million due to a decline in royalties from Sandoz's sales of metoprolol succinate extended-release SYS-CON Media, Sandoz Factory Cited in South Africa - Oct 17, 2008 NC, facility for various GMP deficiencies, including inadequate validation of the production process for generic Toprol XL (metoprolol succinate). FDA news (subscription), Sandoz Gets Warning Letter for Generic Toprol XL Production Operations - Sep 26, 2008 The company manufactures metoprolol succinate at its facility in Wilson, NC The warning letter resulted from a March inspection. FDA news (subscription), Bulgarian Drug Agency takes AstraZeneca heart medicine off the shelves - Oct 15, 2008 In a press statement issued on the morning of October 14, AstraZeneca said that packaging of the metoprolol succinate (a beta-blocker) medication was in Sofia Echo, Beta-Blockers for Primary Prevention of Heart Failure in Patients ... - Oct 3, 2008 The trials included in this meta-analysis did not include trials using carvedilol or long-acting metoprolol succinate, both of which have favorable effects Cardiosource, Once-a-day carvedilol "noninferior" to twice-daily version in ... - Sep 24, 2008 Clinical-trial data support the use of only bisoprolol, metoprolol succinate, and carvedilol in systolic heart failure out of all the available beta TheHeart.Org, FDA Sends Warning Letter to Sandoz Regarding Manufacturing Facility - Aug 26, 2008 Specifically, you have failed to appropriately validate the manufacturing process for Metoprolol Succinate ER (25 and 50 mg) tablets prior to product PharmaLive.com (press release), UPDATE 2-US warns Novartis generic unit on plant problems - Aug 26, 2008 Food and Drug Administration inspectors found the company failed to properly validate the manufacturing process for metoprolol succinate ER tablets before Reuters Should You Be POISEd to Give Perioperative Beta Blockers? - Sep 5, 2008 Effects of Extended-Release Metoprolol Succinate in Patients Undergoing Non-Cardiac Surgery (POISE trial): A Randomized Controlled Trial. Medscape (subscription) FDA finds Sandoz paperwork troubling: Letter cites quality control ... - Aug 27, 2008 The plant, which employs about 450, makes generic medicines, including the heart drug metoprolol succinate, muscle relaxer orphenadrine citrate and Trading Markets (press release), Novartis/Sandoz erhält Verwarnung von US-Gesundheitsbehörde FDA - Aug 26, 2008 Die Verstösse würden den Produktionsbetrieb in Wilson im US-Bundesstaat North Carolina, insbesondere die Herstellung von "Metoprolol Succinate ER"-Tabletten Swissinfo, Novartis: "Good News" zu Glivec und Lucentis - "Gelbe Karte"in den ... - Aug 27, 2008 Die Verstösse würden den Produktionsbetrieb in Wilson im US-Bundesstaat North Carolina, insbesondere die Herstellung von "Metoprolol Succinate ER"-Tabletten Swissinfo, Novartis/Sandoz reçoit un avertissement de la FDA - Aug 26, 2008 Cela concerne le site de production de Wilson, en Caroline du Nord, et la fabrication des comprimés "Metoprolol Succinate ER", apprend-on mardi sur le site swissinfo.ch, FDA, ì‚°ë?„즈ì—? ìƒ?산관리 부실 ê²½ê³ - Aug 27, 2008 ...ê²½ê³ ì„œì‹ ì?€ FDAì?˜ 8ì›” 25ì?¼ìž? 웹사ì?´íŠ¸ì—? 실린 것으로 ì œì¡°ê·œì • 위반ì?´ 아스트ë?¼ ì œë„¤ì¹´ 사ì?˜ í† í”„ë¡¤(Toprol XL)ì?˜ ë³µì œì•½ Metoprolol succinate ER ì •ì œì—? ê´€ë ¨ ë?œ 메디í?¬ë‰´ìŠ¤, Watson Pharmaceuticals Reports Second Quarter 2008 Results - Aug 6, 2008 ...following a 1999 legal settlement, and reflects the addition of royalties from Sandoz's sales of metoprolol succinate extended-release tablets 50mg. PharmaLive.com (press release), KV Pharmaceutical Company Reports Fiscal 2008 Results - Jun 16, 2008 The increase in sales was lower than management anticipated due to the delay in the approval of the 50 mg strength of Metoprolol Succinate Extended-Release Trading Markets (press release), KV Pharmaceutical Company Completes Fiscal 2008 Filings With ... - Jun 25, 2008 The anticipated new products, continued momentum from KV's generic Metoprolol Succinate Extended Release tablets, and expansion of the Company's branded Earthtimes (press release), 2008-06-16, Source: KV Pharmaceutical Company - Jun 17, 2008 ...of 56.1% was achieved through the approval, launch and contribution of two first-to-file strengths of Metoprolol Succinate Extended-Release Tablets. Lifescience-online, : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |